Master Data

Registry
Register court München HRB 287453
Registered
9/18/2023
Industry
Research and experimental development on biotechnologyOther research and experimental development on natural sciences and engineeringActivities of university hospitals
Purpose
Entwicklung und Anwendung neuester Sequenziertechniken zur Bestimmung krankheits- und altersrelevanter genetischer und epigenetischer Daten.

History

No events found for this filter

Management

NameRole
Thomas Dr. Carell
since 9/18/2023
Managing Director

Beneficial Owners
Beta

100.00% identified0.00% unresolved

Identified persons (2)

NameOwnership
75.00%
Birgit Carell
25.00%

Shareholders
Beta

2 shareholders

GmbH structure

Name
Location
Amount
Share
Thomas Carell
Krailling
€6,250
75.00%
Birgit Carell
Krailling
€6,250
25.00%

News & Media Coverage

Insolvency Notices

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)

Organizations at this Address

5 nearby organizations

List of companies and organizations located at or near this business address. Data includes company names, addresses, registration details, and industry classifications.
The information on this page is sourced from public sources, official registries, or provided by third-party providers. Fusionbase does not guarantee the accuracy, completeness, or timeliness of the data. If you have any questions or suggestions, feel free to contact us via the contact form.